Published in Cancer Weekly, June 22nd, 1998
Due to the low water solubility of paclitaxel, researchers have attempted to create water soluble analogs of paclitaxel which retain their anti-cancer activity and are highly stable. Additionally, the development of paclitaxel-resistance in cancer patients undergoing...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.